We are making early stage cancer 100,000x easier to find using extracellular vesicles found in blood, specific to their parent cells.
Location: United States, Massachusetts, Natick
Employees: 11-50
Total raised: $41M
Founded date: 2018
Investors 5
Date | Name | Website |
13.02.2021 | Broadway A... | broadway-a... |
- | iSelect Fu... | iselectfun... |
05.05.2023 | BrightEdge | brightedge... |
26.03.2021 | The Perkin... | theperkins... |
- | BrightEdge | acsbrighte... |
Funding Rounds 1
Date | Series | Amount | Investors |
06.04.2023 | Series A | $41M | - |
Mentions in press and media 3
Date | Title | Description | Source |
06.04.2023 | Extracellular Vesicle-Based Liquid Biopsy Company Mercy BioA... | Mercy BioAnalytics – a pioneer in extracellular vesicle-based liquid biopsies for the early detectio... | pulse2.com... |
03.04.2023 | Mercy BioAnalytics Raises $41M in Series A Funding | Mercy BioAnalytics, a Natick, MA-based company focused on advancing extracellular vesicle-based liqu... | finsmes.co... |
- | Mercy BioAnalytics | “We are making early stage cancer 100,000x easier to find using extracellular vesicles found in bloo... | fastfounde... |